Silver Book Fact

Healthcare costs of atrial fibrillation

Atrial fibrillation (AF) is a major economic burden for society with the biggest cost driver being hospitalizations—accounting for 52% of costs. Drugs for AF account for 23% of costs, consultations at 9%, further investigations at 8%, loss of work at 6%, and paramedical procedures at 2%.

Le Heuzey, J-Y, O Paziaud, O Piot, SM Ait, X Copie, T Lavergne, and L Guize. Cost of Care Distribution in Atrial Fibrillation Patients: The COCAF study. Am Heart J. 2004; 147(1): 121-6. http://www.ahjonline.com/article/S0002-8703%2803%2900524-6/abstract

Reference

Title
Cost of Care Distribution in Atrial Fibrillation Patients: The COCAF study
Publication
Am Heart J
Publication Date
2004
Authors
Le Heuzey, J-Y, O Paziaud, O Piot, SM Ait, X Copie, T Lavergne, and L Guize
Volume & Issue
Volume 147, Issue 1
Pages
121-6
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Annual direct cost of Afib
    Average annual cost comparison between patients with and without atrial fibrillation  
  • The risk of stroke attributable to atrial fibrillation by age
    The risk of stroke attributable to atrial fibrillation increases from 1.5% for those ages 50 to 59 to 23.5% for those ages 80 to 89.  
  • Hospital costs for ischemic stroke
    Hospital costs for nonrecurrent ischemic stroke are 20% higher in patients with atrial fibrillation, than in patients without the disease.  
  • AFib attributed stroke rate by age
    The percentage of strokes attributable to atrial fibrillation increases from 1.5% at ages 50 to 59, to 23.5% at ages 80 to 89.  
  • Atrial fibrillation prevalence projection, 2050
    Atrial fibrillation prevalence is projected to rise to between 5.6 and 12.1 million in 2050.